Results

eNauka >  Rezultati >  Efficacy and tolerability of the investigational topical cream SD-101 (6% allantoin) in patients with epidermolysis bullosa: a phase 3, randomized, double-blind, vehicle-controlled trial (ESSENCE study)
Naziv: Efficacy and tolerability of the investigational topical cream SD-101 (6% allantoin) in patients with epidermolysis bullosa: a phase 3, randomized, double-blind, vehicle-controlled trial (ESSENCE study)
Autori: Paller, Amy S.; Browning, John; Nikolić, Miloš MI  ; Bodemer, Christine; Murrell, Dedee F.; Lenon, Willistine; Krusinska, Eva; Reha, Allen; Lagast, Hjalmar; Barth, Jay A.
Godina: 2020
Publikacija: Orphanet journal of rare diseases
ISSN: 1750-1172 Orphanet Journal of Rare Diseases Pretraži identifikator
Izdavač: [London] : BioMed Central
Tip rezultata: Naučni članak
Kolacija: vol. 15 br. 1 str. 158
DOI: 10.1186/s13023-020-01419-3
WoS-ID: 000544876100001
Scopus-ID: 2-s2.0-85087004309
PMID: 32576219
PMCID: PMC7310548
URI: https://enauka.gov.rs/handle/123456789/810131
URL: https://ojrd.biomedcentral.com/articles/10.1186/s13023-020-01419-3
Projekat: Amicus Therapeutics, Inc.
Izvor metapodataka: (Preuzeto iz Nasi u WoS)
M-kategorija: 
21M21 - Vodeći međunarodni časopis kategorije M21

13
SCOPUSTM
8
PubMed CentralTM
4
OpenCitations
11
WEB OF SCIENCETM
Altmetric
Dimensions
Unpaywall

Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.